Theraclion SA (EPA:ALTHE)

France flag France · Delayed Price · Currency is EUR
0.622
-0.002 (-0.32%)
Feb 27, 2026, 4:48 PM CET
222.28%
Market Cap 29.22M
Revenue (ttm) 1.87M
Net Income (ttm) -5.25M
Shares Out 46.98M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 11,399
Average Volume 41,535
Open 0.626
Previous Close 0.624
Day's Range 0.614 - 0.626
52-Week Range 0.142 - 1.250
Beta -0.11
RSI 46.67
Earnings Date Apr 16, 2026

About Theraclion

Theraclion SA provides therapeutic ultrasound equipment. It offers SONOVEIN, a robotic solution for the non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for the echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment to protect the patient’s skin and optimize image quality. The company was incorporated in 2004 and is headquartered in Malakoff, France. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2004
Employees 31
Stock Exchange Euronext Paris
Ticker Symbol ALTHE
Full Company Profile

Financial Performance

In 2024, Theraclion's revenue was 830,209, a decrease of -54.44% compared to the previous year's 1.82 million. Losses were -5.76 million, 56.7% more than in 2023.

Financial Statements

News

There is no news available yet.